66th Annual Meeting of the Japanese Society of Neurology

Hiroaki Yokote^1,2, Yusei Miyazaki³, Juichi Fujimori⁴, Yoichiro Nishida², Shuta Toru⁵, Masaaki Niino³, Ichiro Nakashima⁴, Yoshiharu Miura¹, Takanori Yokota² (1.Department of Neurology, Tokyo Metropolitan Komagome Hospital, Japan, 2.Department of Neurology and Neurological Science, Institute of Science Tokyo, Japan, 3.Department of Neurology/Clinical Research, National Hospital Organization Hokkaido Medical Center, Japan, 4.Division of Neurology, Tohoku Medical and Pharmaceutical University, Japan, 5.Department of Neurology, Nitobe Memorial Nakano General Hospital, Japan)

Eizo Tanaka^1,2, Yuu-ichi Kira¹, Kazunori Iwao^1,3, Hajime Takeuchi¹, Ayano Matsuyoshi¹, Keisuke Mizutani¹, Siqi Song¹, Masaya Harada^1,4, Mitsuru Watanabe¹, Koji Shinoda¹, Katsuhisa Masaki¹, Noriko Isobe¹ (1.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 2.Miyazaki Prefectural Miyazaki Hospital, Japan, 3.Department of Anatomy and Cell Biology, Graduate School of Medical Sciences, Kyushu University, Japan, 4.Division of Respirology, Neurology and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan)

Katsuichi Miyamoto¹, Keisyu Murakami¹, Mayumi Sakata¹, Shoko Yorozu¹, Nobuaki Nakayama¹, Norimitsu Inoue² (1.Department of Neurology, Wakayama Medical University, Japan, 2.Department of Molecular Genetics, Wakayama Medical University, Japan)

Yusei Miyazaki¹, Hideyuki Takeuchi², Takao Kiriyama³, Hikoaki Fukaura⁴, Juichi Fujimori⁵, Katsuhisa Masaki⁶, Sonoko Misawa⁷, Katsuichi Miyamoto⁸, Nobuaki Yoshikukra⁹, Kengo Nagashima¹⁰, Ichiro Nakashima⁵ (1.National Hospital Organization Hokkaido Medical Center, Japan, 2.International University of Health and Welfare Atami Hospital, Japan, 3.Nara Medical University Hospital, Japan, 4.Saitama Medical Center, Japan, 5.Tohoku Medical and Pharmaceutical University Hospital, Japan, 6.Kyushu University Hospital, Japan, 7.Chiba University Hospital, Japan, 8.Wakayama Medical University Hospital, Japan, 9.Gifu University Hospital, Japan, 10.Keio University Hospital, Japan)

Shinya Hirota¹, Kyoko Kato¹, Hideki Aya¹, Hideaki Hida¹, Muneyoshi Kudo¹, Satoshi Yuki¹, Kazuo Fujihara^2,3 (1.Mitsubishi Tanabe Pharma Corporation, Japan, 2.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Japan, 3.Multiple Sclerosis and Neuromyelitis Optica Center, Southern Tohoku Research Institute for Neuroscience, Japan)

Masayuki Tahara¹, Keisuke Saitoh², Daisuke Mizui², Kohei Nishino², Toshiya Ishihara², Syohei Nomoto², Kwiyoung Park², Masayuki Kohsaka¹, Satoshi Tomita¹, Tomoko Oeda¹, Hideyuki Sawada² (1.Clinical research Center, National Hospital Organization Utano National Hosipital, Japan, 2.Department of Neurology, National Hospital Organization Utano National Hosipital, Japan)